Relmada Therapeutics, Inc. (RLMD) | 2.69% | $24.47M | N/A | N/A | N/A |
Lexicon Pharmaceuticals, Inc. (LXRX) | 2.09% | $254.27M | 2,481.48% | 96.30% | 3.36 |
Sutro Biopharma, Inc. (STRO) | 1.84% | $109.67M | -59.64% | 88.37% | 0.46 |
Exagen, Inc. (XGN) | 1.63% | $104.70M | 5.89% | 59.51% | 1.37 |
Sol-Gel Technologies Ltd. (SLGL) | 1.62% | $21.62M | 2,416.90% | N/A | -0.67 |
Allakos, Inc. (ALLK) | 1.42% | $29.46M | N/A | N/A | N/A |
Kodiak Sciences, Inc. (KOD) | 1.38% | $221.08M | N/A | N/A | N/A |
Ocugen, Inc. (OCGN) | 1.32% | $215.19M | -32.82% | 51.47% | 47.38 |
IRIDEX Corp. (IRIX) | 1.27% | $19.48M | -6.17% | 39.39% | 0.63 |
IGM Biosciences, Inc. (IGMS) | 1.26% | $82.49M | 25.77% | -240.13% | 86.22 |
SIGA Technologies, Inc. (SIGA) | 1.25% | $462.91M | -0.86% | 77.44% | 2.00 |
CytomX Therapeutics, Inc. (CTMX) | 1.24% | $61.34M | 36.45% | 98.72% | -0.03 |
Atara Biotherapeutics, Inc. (ATRA) | 1.24% | $44.53M | 1,404.02% | 83.71% | 1.09 |
ESSA Pharma, Inc. (EPIX) | 1.23% | $79.90M | N/A | N/A | N/A |
Verastem, Inc. (VSTM) | 1.22% | $386.17M | N/A | 99.74% | 13.81 |
SELLAS Life Sciences Group, Inc. (SLS) | 1.21% | $121.73M | N/A | N/A | N/A |
VYNE Therapeutics, Inc. (VYNE) | 1.19% | $28.59M | 18.16% | 99.20% | 162.19 |
KalVista Pharmaceuticals, Inc. (KALV) | 1.18% | $640.34M | N/A | N/A | N/A |
Neoleukin Therapeutics, Inc. (NLTX) | 1.17% | $228.32M | N/A | -251.03% | 109.84 |
Akebia Therapeutics, Inc. (AKBA) | 1.16% | $595.61M | -17.70% | 57.03% | 3.39 |
Ocular Therapeutix, Inc. (OCUL) | 1.14% | $1.26B | 9.03% | 91.17% | 16.25 |
Abeona Therapeutics, Inc. (ABEO) | 1.14% | $263.03M | -100.00% | N/A | N/A |
CARA Therapeutics, Inc. (CARA) | 1.13% | $27.12M | -65.96% | 88.62% | 4.83 |
Daré Bioscience, Inc. (DARE) | 1.12% | $26.55M | -99.65% | -5,146.61% | 1,723.91 |
InflaRx NV (IFRX) | 1.12% | $88.62M | 162.93% | -2,175.50% | 511.07 |
SCYNEXIS, Inc. (SCYX) | 1.11% | $41.51M | -97.33% | N/A | 4.07 |
SOPHiA GENETICS SA (SOPH) | 1.10% | $203.83M | 4.49% | 59.63% | 2.34 |
Precision BioSciences, Inc. (DTIL) | 1.10% | $57.65M | 40.98% | 93.34% | -0.44 |
MediciNova, Inc. (MNOV) | 1.09% | $75.53M | -100.00% | N/A | N/A |
Inovio Pharmaceuticals, Inc. (INO) | 1.09% | $70.41M | -73.83% | -1,337.41% | -149.45 |
Immunic, Inc. (IMUX) | 1.08% | $109.23M | N/A | N/A | N/A |
Oramed Pharmaceuticals, Inc. (ORMP) | 1.07% | $93.96M | -100.00% | N/A | N/A |
Trevi Therapeutics, Inc. (TRVI) | 1.07% | $613.93M | N/A | N/A | N/A |
Leap Therapeutics, Inc. (LPTX) | 1.06% | $16.22M | N/A | N/A | N/A |
Minerva Neurosciences, Inc. (NERV) | 1.06% | $12.24M | N/A | N/A | N/A |
Cognition Therapeutics, Inc. (CGTX) | 1.06% | $27.35M | N/A | N/A | N/A |
PDS Biotechnology Corp. (PDSB) | 1.05% | $59.92M | N/A | N/A | N/A |
Mind Medicine (MindMed), Inc. (MNMD) | 1.04% | $484.62M | N/A | N/A | N/A |
Assembly Biosciences, Inc. (ASMB) | 1.04% | $79.01M | 298.16% | 99.55% | -0.50 |
Cidara Therapeutics, Inc. (CDTX) | 1.04% | $235.28M | -98.00% | 81.73% | -17.19 |
InspireMD, Inc. (NSPR) | 1.03% | $79.65M | 12.96% | 21.49% | 11.12 |
electroCore, Inc. (ECOR) | 1.03% | $54.31M | 57.09% | 84.97% | 4.50 |
Vivani Medical, Inc. (EYES) | 1.03% | $61.02M | N/A | N/A | N/A |
Rigel Pharmaceuticals, Inc. (RIGL) | 1.03% | $340.54M | 53.38% | 89.60% | 1.56 |
Annovis Bio, Inc. (ANVS) | 1.02% | $31.96M | N/A | N/A | N/A |
aTyr Pharma, Inc. (LIFE) | 1.02% | $306.56M | -33.43% | -555.32% | 892.75 |
NeuroPace, Inc. (NPCE) | 1.02% | $368.47M | 22.14% | 73.94% | 4.34 |
ProQR Therapeutics NV (PRQR) | 1.02% | $162.03M | 190.38% | 85.40% | 4.38 |
Larimar Therapeutics, Inc. (LRMR) | 1.01% | $151.75M | N/A | N/A | N/A |
Karyopharm Therapeutics, Inc. (KPTI) | 1.01% | $51.16M | -0.55% | 95.63% | 1.16 |
GlycoMimetics, Inc. (GLYC) | 1.01% | $16.17M | -100.00% | N/A | N/A |
Enlivex Therapeutics Ltd. (ENLV) | 1.00% | $21.11M | N/A | N/A | N/A |
Acumen Pharmaceuticals, Inc. (ABOS) | 1.00% | $66.63M | N/A | N/A | N/A |
Axogen, Inc. (AXGN) | 0.99% | $716.60M | 17.81% | 75.79% | 4.05 |
Voyager Therapeutics, Inc. (VYGR) | 0.99% | $194.88M | -68.00% | 94.09% | 1.30 |
Vanda Pharmaceuticals, Inc. (VNDA) | 0.98% | $251.34M | 3.18% | 90.65% | -0.42 |
Galectin Therapeutics, Inc. (GALT) | 0.97% | $89.72M | N/A | N/A | N/A |
Atea Pharmaceuticals, Inc. (AVIR) | 0.97% | $245.46M | N/A | N/A | N/A |
Spero Therapeutics, Inc. (SPRO) | 0.96% | $40.53M | -71.68% | 99.99% | 0.26 |
Delcath Systems, Inc. (DCTH) | 0.96% | $403.20M | 1,701.69% | 83.37% | 7.82 |
Precigen, Inc. (PGEN) | 0.95% | $467.53M | -36.95% | -86.65% | 60.04 |
XBiotech, Inc. (XBIT) | 0.93% | $90.24M | N/A | N/A | N/A |
Nektar Therapeutics (NKTR) | 0.93% | $137.40M | 9.22% | 67.54% | 1.32 |
Lifeward Ltd. (RWLK) | 0.93% | $15.63M | 85.24% | 32.01% | 0.35 |
Anixa Biosciences, Inc. (ANIX) | 0.93% | $86.93M | N/A | N/A | N/A |
Achieve Life Sciences, Inc. (ACHV) | 0.93% | $83.24M | N/A | N/A | N/A |
Mersana Therapeutics, Inc. (MRSN) | 0.93% | $45.15M | 9.88% | 95.98% | 1.71 |
PMV Pharmaceuticals, Inc. (PMVP) | 0.92% | $56.09M | N/A | N/A | N/A |
Cellectar Biosciences, Inc. (CLRB) | 0.92% | $14.42M | N/A | N/A | N/A |
ADC Therapeutics SA (ADCT) | 0.92% | $134.88M | 1.84% | 86.98% | 0.92 |
Vistagen Therapeutics, Inc. (VTGN) | 0.91% | $67.54M | -43.12% | 31.20% | 5.37 |
CorMedix, Inc. (CRMD) | 0.91% | $596.41M | N/A | 92.66% | 9.79 |
DiaMedica Therapeutics, Inc. (DMAC) | 0.91% | $178.71M | N/A | N/A | N/A |
Verrica Pharmaceuticals, Inc. (VRCA) | 0.91% | $43.13M | 47.66% | 63.79% | 4.74 |
Actinium Pharmaceuticals, Inc. (ATNM) | 0.89% | $39.62M | -100.00% | N/A | N/A |
Astria Therapeutics, Inc. (ATXS) | 0.89% | $294.02M | N/A | N/A | N/A |
Immuneering Corp. (IMRX) | 0.88% | $52.54M | N/A | N/A | N/A |
BioVie, Inc. (BIVI) | 0.87% | $16.50M | N/A | N/A | N/A |
Solid Biosciences, Inc. (SLDB) | 0.87% | $284.40M | N/A | N/A | N/A |
Annexon, Inc. (ANNX) | 0.87% | $209.55M | N/A | N/A | N/A |
AC Immune SA (ACIU) | 0.86% | $164.25M | 88.28% | N/A | 2.98 |
Cardiff Oncology, Inc. (CRDF) | 0.84% | $192.92M | 39.96% | 40.85% | 170.69 |
Tempest Therapeutics, Inc. (TPST) | 0.82% | $28.34M | N/A | N/A | N/A |
Whitehawk Therapeutics, Inc. (AADI) | 0.80% | $70.64M | 6.69% | 88.36% | 1.50 |
CollPlant Biotechnologies Ltd. (CLGN) | 0.78% | $25.31M | -95.30% | -417.09% | 62.44 |
Kineta, Inc. (YMTX) | 0.76% | $3.50M | -100.00% | N/A | N/A |
Opus Genetics, Inc. (OCUP) | 0.69% | $37.75M | -42.30% | 99.91% | 1.85 |
Syros Pharmaceuticals, Inc. (SYRS) | 0.69% | $1.04M | -100.00% | N/A | 224.15 |
Curis, Inc. (CRIS) | 0.65% | $16.53M | 8.83% | 97.24% | 3.34 |
AlloVir, Inc. (ALVR) | 0.65% | $32.87M | N/A | N/A | N/A |
Adverum Biotechnologies, Inc. (ADVM) | 0.64% | $62.04M | -72.22% | -265.30% | 58.40 |
Lyra Therapeutics, Inc. (LYRA) | 0.62% | $6.53M | -1.54% | 69.30% | 4.72 |
Esperion Therapeutics, Inc. (ESPR) | 0.57% | $174.63M | 185.66% | 79.36% | 2.58 |
Carisma Therapeutics, Inc. (SESN) | 0.57% | $8.99M | 31.59% | 82.92% | 0.10 |
Accelerate Diagnostics, Inc. (AXDX) | 0.56% | $13.73M | -2.99% | 23.12% | 6.69 |
Galecto, Inc. (GLTO) | 0.51% | $3.77M | N/A | N/A | N/A |
Aldeyra Therapeutics, Inc. (ALDX) | 0.45% | $158.23M | N/A | N/A | N/A |